Bahrain vs Portugal: Cause of death, by non-communicable diseases, ages 60+, male
Bahrain
80.5%
in 2021
Portugal
80.3%
in 2021
Bahrain rank
38th
Portugal rank
40th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Bahrain
- Portugal
How they compare
Bahrain currently reports 80.5% against 80.3% in Portugal, a difference of 0.2%.
Across all 6 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 38th and Portugal ranks 40th of 185 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.8% | 89.6% | 3.2% | Bahrain |
| 2010s | 93.7% | 87.6% | 6.0% | Bahrain |
| 2020s | 83.1% | 80.9% | 2.2% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Bahrain or Portugal?
- Bahrain, at 80.5% against 80.3% in Portugal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Bahrain and Portugal?
- 0.2%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Portugal?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahrain and Portugal rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Bahrain ranks 38th and Portugal ranks 40th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.